Protagonist Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 10.22 M | $460.09 M | 100.00% | 16.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 5.86 M | $263.75 M | 0.35% | 9.49% |
| RTW INVESTMENTS, LP | 11/14/2024 | 5.43 M | $244.18 M | 2.64% | 8.78% |
| VANGUARD GROUP INC | 11/13/2024 | 4.22 M | $189.72 M | 29.99% | 6.83% |
| STATE STREET CORP | 11/14/2024 | 3.18 M | $143.26 M | 52.88% | 5.15% |
| JOHNSON & JOHNSON | 11/13/2024 | 2.45 M | $110.21 M | 0.00% | 3.97% |
| BVF INC/IL | 11/14/2024 | 1.85 M | $83.26 M | -44.26% | 3.00% |
| JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 1.81 M | $81.66 M | -11.07% | 2.94% |
| PACER ADVISORS, INC. | 11/12/2024 | 1.73 M | $78.03 M | 405,061.22% | 2.81% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.37 M | $61.87 M | 0.26% | 2.23% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 1.37 M | $61.86 M | 8.34% | 2.23% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.31 M | $58.93 M | 8.26% | 2.12% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 1.20 M | $54.04 M | -40.00% | 1.94% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 981,295 | $44.16 M | -38.82% | 1.59% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 821,856 | $36.98 M | 39.12% | 1.33% |
| INVESCO LTD. | 11/12/2024 | 653,152 | $29.39 M | 638.58% | 1.06% |
| MORGAN STANLEY | 11/14/2024 | 628,623 | $28.29 M | 82.06% | 1.02% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 574,775 | $25.86 M | 2,004.55% | 0.93% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 565,503 | $25.45 M | 7.58% | 0.92% |
| JPMORGAN CHASE & CO | 12/26/2024 | 502,985 | $22.63 M | 33.56% | 0.81% |
| WOODLINE PARTNERS LP | 11/14/2024 | 466,518 | $20.99 M | -43.26% | 0.76% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 456,369 | $20.54 M | -42.95% | 0.74% |
| FMR LLC | 11/13/2024 | 454,196 | $20.44 M | 4.54% | 0.74% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 445,352 | $20.04 M | -20.02% | 0.72% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 445,204 | $20.03 M | -11.99% | 0.72% |
| MANGROVE PARTNERS | 11/14/2024 | 439,314 | $19.77 M | 0.00% | 0.71% |
| COLONY GROUP, LLC | 11/14/2024 | 426,661 | $19.20 M | 100.00% | 0.69% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 420,000 | $18.90 M | -30.52% | 0.68% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 356,333 | $16.04 M | 74.42% | 0.58% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 350,000 | $15.75 M | 100.00% | 0.57% |
| COWEN AND COMPANY, LLC | 11/12/2024 | 340,974 | $15.34 M | -71.16% | 0.55% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 322,989 | $14.53 M | -28.72% | 0.52% |
| PRINCIPAL FINANCIAL GROUP INC | 12/19/2024 | 320,832 | $14.44 M | 3,099.36% | 0.52% |
| MARSHALL WACE, LLP | 11/14/2024 | 315,373 | $14.19 M | -44.88% | 0.51% |
| EAGLE ASSET MANAGEMENT INC | 11/12/2024 | 294,280 | $13.60 M | -17.71% | 0.48% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 267,033 | $12.02 M | -7.95% | 0.43% |
| CHECKPOINT CAPITAL L.P. | 11/14/2024 | 240,000 | $10.80 M | -32.39% | 0.39% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 232,074 | $10.44 M | -37.95% | 0.38% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 11/07/2024 | 230,114 | $10.36 M | 1,116.63% | 0.37% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 225,589 | $10.15 M | -63.39% | 0.37% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 214,872 | $9.67 M | -76.38% | 0.35% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 172,202 | $7.67 M | 16.12% | 0.28% |
| RHUMBLINE ADVISERS | 11/12/2024 | 164,178 | $7.39 M | 93.21% | 0.27% |
| CANDRIAM S.C.A. | 11/13/2024 | 162,492 | $7.31 M | -40.66% | 0.26% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/14/2024 | 158,067 | $7.11 M | 100.00% | 0.26% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 157,414 | $7.08 M | 164.40% | 0.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 146,657 | $6.60 M | 100.00% | 0.24% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 144,167 | $6.49 M | -51.54% | 0.23% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 143,807 | $6.47 M | 100.00% | 0.23% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 140,924 | $6.34 M | 6.91% | 0.23% |
Protagonist Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 276 institutional investors and hedge funds held shares of Protagonist Therapeutics, Inc.. The most heavily invested institutionals were:
EVERENCE CAPITAL MANAGEMENT INC: 0
BlackRock Funding, Inc. /DE: 10.22 M
FARALLON CAPITAL MANAGEMENT LLC: 5.86 M
RTW INVESTMENTS, LP: 5.43 M
VANGUARD GROUP INC: 4.22 M
STATE STREET CORP: 3.18 M
99.93% of Protagonist Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 70.83 M shares in the last 24 months. This purchase volume represents approximately $2.60 B in transactions.